Variant report

Variant	nsv582529
Chromosome Location	chr2:100687778-100753490
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:353)
CpG islands
(count:977)
Chromatin interactive
region (count:9)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:353 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:100687825-100687954	HepG2	liver:	n/a	n/a
2	ATF2	chr2:100729982-100730828	GM12878	blood:	n/a	n/a
3	ATF2	chr2:100752664-100753293	GM12878	blood:	n/a	n/a
4	ATF2	chr2:100752310-100753333	GM12878	blood:	n/a	n/a
5	ATF2	chr2:100747344-100747802	GM12878	blood:	n/a	n/a
6	BACH1	chr2:100721784-100721890	H1-hESC	embryonic stem cell:	n/a	n/a
7	BATF	chr2:100752314-100753166	GM12878	blood:	n/a	n/a
8	BATF	chr2:100751879-100752301	GM12878	blood:	n/a	n/a
9	BATF	chr2:100747519-100747756	GM12878	blood:	n/a	n/a
10	BATF	chr2:100752739-100753152	GM12878	blood:	n/a	n/a
11	BATF	chr2:100747403-100747828	GM12878	blood:	n/a	chr2:100747811-100747821
12	BATF	chr2:100718925-100719646	GM12878	blood:	n/a	n/a
13	BATF	chr2:100718898-100719582	GM12878	blood:	n/a	n/a
14	BCL11A	chr2:100735674-100736000	H1-hESC	embryonic stem cell:	n/a	n/a
15	BCL11A	chr2:100718979-100719530	GM12878	blood:	n/a	n/a
16	BCL11A	chr2:100718827-100719589	GM12878	blood:	n/a	n/a
17	BCL11A	chr2:100752655-100753226	GM12878	blood:	n/a	n/a
18	BCL3	chr2:100752733-100753136	GM12878	blood:	n/a	n/a
19	BCL3	chr2:100752825-100753164	GM12878	blood:	n/a	n/a
20	BCLAF1	chr2:100730299-100730947	GM12878	blood:	n/a	n/a
21	BCLAF1	chr2:100752714-100753166	GM12878	blood:	n/a	n/a
22	BCLAF1	chr2:100747373-100747722	GM12878	blood:	n/a	n/a
23	BCLAF1	chr2:100752319-100753211	GM12878	blood:	n/a	n/a
24	BHLHE40	chr2:100752811-100753209	GM12878	blood:	n/a	n/a
25	BHLHE40	chr2:100710140-100710442	HepG2	liver:	n/a	chr2:100710250-100710263
26	CCNT2	chr2:100742029-100742224	K562	blood:	n/a	n/a
27	CEBPB	chr2:100690842-100691144	HepG2	liver:	n/a	chr2:100690983-100690994
28	CEBPB	chr2:100712214-100712246	A549	lung:	n/a	chr2:100712226-100712235 chr2:100712225-100712236 chr2:100712224-100712237
29	CEBPB	chr2:100712118-100712355	HepG2	liver:	n/a	chr2:100712226-100712235 chr2:100712225-100712236 chr2:100712224-100712237
30	CEBPB	chr2:100687757-100688332	IMR90	lung:	n/a	chr2:100687864-100687881 chr2:100687866-100687877 chr2:100687865-100687876 chr2:100687865-100687878
31	CEBPB	chr2:100741288-100741647	Hela-S3	cervix:	n/a	chr2:100741312-100741323
32	CEBPB	chr2:100690943-100691000	K562	blood:	n/a	chr2:100690983-100690994
33	CEBPB	chr2:100687728-100688292	HepG2	liver:	n/a	chr2:100687864-100687881 chr2:100687866-100687877 chr2:100687865-100687876 chr2:100687865-100687878
34	CEBPB	chr2:100687754-100688054	A549	lung:	n/a	chr2:100687864-100687881 chr2:100687866-100687877 chr2:100687865-100687876 chr2:100687865-100687878
35	CEBPB	chr2:100752861-100753113	GM12878	blood:	n/a	n/a
36	CEBPB	chr2:100696050-100696105	HepG2	liver:	n/a	chr2:100696077-100696088 chr2:100696076-100696089
37	CEBPB	chr2:100752678-100753351	GM12878	blood:	n/a	n/a
38	CEBPB	chr2:100690895-100691091	A549	lung:	n/a	chr2:100690983-100690994
39	CEBPB	chr2:100699028-100699222	IMR90	lung:	n/a	chr2:100699083-100699096 chr2:100699083-100699096
40	CEBPB	chr2:100712097-100712304	IMR90	lung:	n/a	chr2:100712226-100712235 chr2:100712225-100712236 chr2:100712224-100712237
41	CHD1	chr2:100722865-100723049	H1-hESC	embryonic stem cell:	n/a	n/a
42	CHD2	chr2:100722887-100723124	H1-hESC	embryonic stem cell:	n/a	n/a
43	CREB1	chr2:100752609-100753200	GM12878	blood:	n/a	n/a
44	CTBP2	chr2:100722914-100723365	H1-hESC	embryonic stem cell:	n/a	n/a
45	CTBP2	chr2:100721806-100722653	H1-hESC	embryonic stem cell:	n/a	n/a
46	CTCF	chr2:100738640-100738790	GM12864	blood:	n/a	n/a
47	CTCF	chr2:100727615-100727655	K562	blood:	n/a	n/a
48	CTCF	chr2:100707566-100707573	GM10266	blood:	n/a	n/a
49	CTCF	chr2:100712384-100712561	K562	blood:	n/a	n/a
50	CTCF	chr2:100698783-100698836	LNCaP	prostate:	n/a	n/a

(count:977 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:100722022-100722072	Caco-2	colon:	n/a
2	chr2:100722022-100722072	Caco-2	colon:	n/a
3	chr2:100722022-100722072	SK-N-MC	brain:	n/a
4	chr2:100689798-100689848	A549	lung:	n/a
5	chr2:100721844-100721894	HepG2	liver:	n/a
6	chr2:100722022-100722072	T-47D	breast:	n/a
7	chr2:100689798-100689848	HEK293	kidney:	embryo
8	chr2:100722155-100722205	HEK293	kidney:	embryo
9	chr2:100722022-100722072	U87	brain:	n/a
10	chr2:100691631-100691681	PrEC	prostate:	n/a
11	chr2:100723417-100723467	HAEpiC	amniotic membrane:	n/a
12	chr2:100720529-100720579	BE2_C	brain:	n/a
13	chr2:100720526-100720576	LNCaP	prostate:	n/a
14	chr2:100720529-100720579	Hela-S3	cervix:	n/a
15	chr2:100720529-100720579	NH-A	brain:	n/a
16	chr2:100722584-100722634	HRPEpiC	eye:	n/a
17	chr2:100722474-100722524	Hepatocyte	liver:	n/a
18	chr2:100722474-100722524	NHDF-neo	bronchial:	n/a
19	chr2:100723110-100723160	NHBE	bronchial:	n/a
20	chr2:100722584-100722634	AG09309	skin:	n/a
21	chr2:100689798-100689848	NH-A	brain:	n/a
22	chr2:100722155-100722205	A549	lung:	n/a
23	chr2:100723240-100723290	ECC-1	luminal epithelium:	n/a
24	chr2:100691631-100691681	HRPEpiC	eye:	n/a
25	chr2:100722155-100722205	LNCaP	prostate:	n/a
26	chr2:100723110-100723160	HEK293	kidney:	embryo
27	chr2:100722474-100722524	ovcar-3	ovarian:	n/a
28	chr2:100720179-100720229	AG09309	skin:	n/a
29	chr2:100721038-100721088	ECC-1	luminal epithelium:	n/a
30	chr2:100722584-100722634	HRE	kidney:	n/a
31	chr2:100722155-100722205	Jurkat	blood:	n/a
32	chr2:100723417-100723467	GM06990	blood:	n/a
33	chr2:100720529-100720579	PrEC	prostate:	n/a
34	chr2:100722408-100722458	HEK293	kidney:	embryo
35	chr2:100721038-100721088	SAEC	small airway:	n/a
36	chr2:100691631-100691681	HRE	kidney:	n/a
37	chr2:100722155-100722205	HRPEpiC	eye:	n/a
38	chr2:100723417-100723467	T-47D	breast:	n/a
39	chr2:100722474-100722524	AG04450	lung:	fetal
40	chr2:100723110-100723160	BE2_C	brain:	n/a
41	chr2:100723110-100723160	ECC-1	luminal epithelium:	n/a
42	chr2:100720529-100720579	HepG2	liver:	n/a
43	chr2:100720179-100720229	U87	brain:	n/a
44	chr2:100723240-100723290	GM12878	blood:	n/a
45	chr2:100722474-100722524	HRPEpiC	eye:	n/a
46	chr2:100718912-100718962	NHBE	bronchial:	n/a
47	chr2:100722155-100722205	NT2-D1	testis:	n/a
48	chr2:100722408-100722458	ECC-1	luminal epithelium:	n/a
49	chr2:100689798-100689848	AG04450	lung:	fetal
50	chr2:100723110-100723160	HAEpiC	amniotic membrane:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:100729149..100730802-chr2:100730864..100732886,2	MCF-7	breast:
2	chr2:100729149..100730802-chr2:100730864..100732886,2	MCF-7	breast:
3	chr2:100696366..100696914-chr3:29677129..29677707,2	MCF-7	breast:
4	chr2:100683259..100685948-chr2:100686167..100688772,2	MCF-7	breast:
5	chr2:100740146..100742521-chr2:100744852..100747122,2	K562	blood:
6	chr2:100750345..100752144-chr2:100764723..100766529,2	MCF-7	breast:
7	chr2:100740146..100742521-chr2:100744852..100747122,2	K562	blood:
8	chr2:100658557..100661534-chr2:100689369..100692116,2	MCF-7	breast:
9	chr2:100721042..100723479-chr2:100726255..100727989,2	MCF-7	breast:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LONRF2-2	chr2:100705714-100705776	NONHSAT072768
2	lnc-LONRF2-2	chr2:100705115-100705287	NONHSAT072768
3	lnc-AFF3-1	chr2:100728848-100728986	NONHSAT072770
4	lnc-AFF3-1	chr2:100726307-100726795	NONHSAT072770
5	lnc-AFF3-1	chr2:100745686-100745768	NONHSAT072770
6	lnc-NMS-2	chr2:100721381-100723966	ENSG00000230393.1

No data

Variant related genes	Relation type
AFF3	TF binding region
ENSG00000230393	TF binding region
AFF3	CpG island
ENSG00000230393	CpG island
ENSG00000144218	chromatin interactions
ENSG00000230393	chromatin interactions

Extended variants
information (count: 1936 )
Associated
traits (count: 52 )

Variant overlapped rSNPs/rCNVs (count:1936 , 50 per page) page: 1 2 3 4 5 6 7 ... 39

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1370355	chr2:100687778-100687779	Weak transcription Enhancers Strong transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs201467904	chr2:100687805-100687806	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs144635928	chr2:100687856-100687857	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs138528173	chr2:100687877-100687878	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs561854272	chr2:100687933-100687934	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs527431285	chr2:100687979-100687980	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs547282260	chr2:100687980-100687981	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs564316979	chr2:100687981-100687982	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs141577315	chr2:100687986-100687987	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs113392903	chr2:100688028-100688029	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs114095862	chr2:100688029-100688030	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs569260829	chr2:100688045-100688046	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs372595313	chr2:100688078-100688079	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs559075651	chr2:100688089-100688090	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs537869184	chr2:100688091-100688092	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs548836546	chr2:100688097-100688098	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs568662466	chr2:100688139-100688140	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs534362109	chr2:100688163-100688164	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs371155334	chr2:100688176-100688177	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs570978720	chr2:100688181-100688182	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs577050444	chr2:100688187-100688188	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs376699576	chr2:100688207-100688208	Weak transcription Strong transcription Flanking Active TSS Genic enhancers Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs190720431	chr2:100688219-100688220	Weak transcription Strong transcription Flanking Active TSS Genic enhancers Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs201168177	chr2:100688254-100688255	Weak transcription Strong transcription Flanking Active TSS Genic enhancers Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs182672577	chr2:100688256-100688257	Weak transcription Strong transcription Flanking Active TSS Genic enhancers Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs187990678	chr2:100688260-100688261	Weak transcription Strong transcription Flanking Active TSS Genic enhancers Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs143439020	chr2:100688372-100688373	Weak transcription Strong transcription Flanking Active TSS Genic enhancers Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs374139517	chr2:100688421-100688422	Weak transcription Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs148068575	chr2:100688580-100688581	Weak transcription Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs572234298	chr2:100688638-100688639	Genic enhancers Strong transcription Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs114549088	chr2:100688642-100688643	Genic enhancers Strong transcription Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs192370096	chr2:100688684-100688685	Genic enhancers Strong transcription Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs13019124	chr2:100688701-100688702	Genic enhancers Strong transcription Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs552670469	chr2:100688717-100688718	Genic enhancers Strong transcription Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs574486510	chr2:100688720-100688721	Genic enhancers Strong transcription Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs115016305	chr2:100688738-100688739	Genic enhancers Strong transcription Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs531685198	chr2:100688742-100688743	Genic enhancers Strong transcription Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs376222984	chr2:100688751-100688752	Genic enhancers Strong transcription Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs548302812	chr2:100688802-100688803	Genic enhancers Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs568488344	chr2:100688876-100688877	Genic enhancers Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs541869581	chr2:100688881-100688882	Genic enhancers Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs114062777	chr2:100688882-100688883	Genic enhancers Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs570676499	chr2:100688904-100688905	Genic enhancers Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs116430789	chr2:100688927-100688928	Genic enhancers Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs555791203	chr2:100688972-100688973	Genic enhancers Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs576061730	chr2:100689015-100689016	Genic enhancers Enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs535575739	chr2:100689026-100689027	Genic enhancers Enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs555067961	chr2:100689027-100689028	Genic enhancers Enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs183072093	chr2:100689037-100689038	Genic enhancers Enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs540954143	chr2:100689048-100689049	Genic enhancers Enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:52)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	17483303	CNVD
Medulloblastoma	20607354	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Ovarian cancer	21781307	CNVD
Lung cancer	18438408	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	21509527	CNVD
small cell lung cancer	20016488	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Glioblastoma multiforme	21138945	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:852 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:100664400-100699600	Weak transcription	Aorta	Aorta
2	chr2:100667800-100688000	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
3	chr2:100679600-100689600	Weak transcription	Spleen	Spleen
4	chr2:100680600-100687800	Enhancers	Dnd41	blood
5	chr2:100683000-100689000	Weak transcription	Primary hematopoietic stem cells	blood
6	chr2:100683000-100698200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr2:100683200-100687800	Strong transcription	Primary B cells from cord blood	blood
8	chr2:100683200-100687800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
9	chr2:100683200-100688600	Weak transcription	Fetal Brain Female	brain
10	chr2:100683200-100719600	Weak transcription	Brain Germinal Matrix	brain
11	chr2:100684400-100690600	Weak transcription	Adipose Nuclei	Adipose
12	chr2:100685000-100688400	Weak transcription	Right Atrium	heart
13	chr2:100685200-100687800	Weak transcription	Fetal Heart	heart
14	chr2:100685400-100688000	Weak transcription	Left Ventricle	heart
15	chr2:100685400-100688600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
16	chr2:100685400-100689000	Weak transcription	Gastric	stomach
17	chr2:100685400-100689000	Weak transcription	Ovary	ovary
18	chr2:100685800-100688600	Enhancers	Fetal Lung	lung
19	chr2:100686000-100698400	Strong transcription	Primary B cells from peripheral blood	blood
20	chr2:100686200-100688800	Enhancers	Fetal Brain Male	brain
21	chr2:100686400-100689000	Enhancers	Thymus	Thymus
22	chr2:100686600-100689000	Enhancers	Primary T cells from cord blood	blood
23	chr2:100686800-100687800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
24	chr2:100686800-100687800	Weak transcription	Monocytes-CD14+_RO01746	blood
25	chr2:100687000-100688000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
26	chr2:100687000-100689200	Enhancers	Fetal Thymus	thymus
27	chr2:100687400-100690400	Weak transcription	Fetal Intestine Small	intestine
28	chr2:100687600-100687800	Enhancers	Primary T helper cells fromperipheralblood	blood
29	chr2:100687600-100688000	Enhancers	Primary monocytes fromperipheralblood	blood
30	chr2:100687600-100688600	Bivalent Enhancer	HepG2	liver
31	chr2:100687800-100688000	Active TSS	Monocytes-CD14+_RO01746	blood
32	chr2:100687800-100688200	Enhancers	Primary neutrophils fromperipheralblood	blood
33	chr2:100687800-100688400	Genic enhancers	Primary B cells from cord blood	blood
34	chr2:100687800-100688600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
35	chr2:100687800-100688600	Flanking Active TSS	Dnd41	blood
36	chr2:100687800-100688800	Strong transcription	IMR90 fetal lung fibroblasts Cell Line	lung
37	chr2:100687800-100689000	Enhancers	Primary T cells fromperipheralblood	blood
38	chr2:100687800-100689000	Enhancers	Fetal Heart	heart
39	chr2:100688000-100688400	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
40	chr2:100688000-100688400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
41	chr2:100688000-100688600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
42	chr2:100688000-100689000	Enhancers	Left Ventricle	heart
43	chr2:100688000-100689200	Enhancers	Primary hematopoietic stem cells short term culture	blood
44	chr2:100688200-100688400	Enhancers	Primary T helper cells PMA-I stimulated	--
45	chr2:100688400-100689000	Enhancers	Right Atrium	heart
46	chr2:100688400-100689200	Enhancers	Primary monocytes fromperipheralblood	blood
47	chr2:100688400-100690000	Enhancers	Right Ventricle	heart
48	chr2:100688400-100696800	Strong transcription	Primary B cells from cord blood	blood
49	chr2:100688400-100710800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
50	chr2:100688600-100689000	Strong transcription	Fetal Brain Female	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links